Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Facioscapulohumeral dystrophy.

J T Kissel1

  • 1Department of Neurology, Ohio State University, School of Medicine, Columbus 43210, USA.

Seminars in Neurology
|March 11, 2000
PubMed
Summary
This summary is machine-generated.

Facioscapulohumeral dystrophy (FSHD) is a common inherited muscle disorder affecting the face and shoulders. While linked to a specific genetic marker on chromosome 4, its exact cause and effective treatments remain elusive.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mutant small heat shock protein B3 causes motor neuropathy: utility of a candidate gene approach.

Neurology·2010
Same author

A 49-year-old man with contractures, weakness, and cardiac arrhythmia.

Neurology·2009
Same author

Post-radiation lower motor neuron syndrome.

Journal of clinical neuromuscular disease·2008
Same author

Fine-mapping the gene for X-linked myopathy with excessive autophagy.

Neurology·2008
Same author

Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy.

Neurology·2007
Same author

Pilot trial of diltiazem in facioscapulohumeral muscular dystrophy.

Neurology·2007
Same journal

Isolated Cranial Tremors: A Reappraisal.

Seminars in neurology·2026
Same journal

Dystonia and Tremor.

Seminars in neurology·2026
Same journal

Pendular nystagmus and oculopalatal tremor.

Seminars in neurology·2026
Same journal

Sanjay Pandey, MBBS, MD, DNB, DM, FIAN, and Aasef Shaikh, MD, PhD.

Seminars in neurology·2026
Same journal

Tremor.

Seminars in neurology·2026
Same journal

Carotid Disease.

Seminars in neurology·2026
See all related articles

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Facioscapulohumeral dystrophy (FSHD) is a prevalent inherited neuromuscular disorder affecting facial and scapular muscles.
  • It presents with autosomal dominant inheritance, though de novo mutations occur, with symptoms typically appearing in childhood.
  • The disease progresses slowly, but the underlying cause and specific gene responsible for FSHD are yet to be identified.

Purpose of the Study:

  • To summarize the current understanding of Facioscapulohumeral dystrophy (FSHD).
  • To highlight the genetic linkage and observed molecular markers associated with FSHD.
  • To underscore the lack of effective treatments and the need for further research into disease mechanisms.

Main Methods:

  • Review of existing literature on Facioscapulohumeral dystrophy (FSHD) genetics and clinical presentation.

Related Experiment Videos

  • Analysis of genetic linkage studies identifying a locus on chromosome 4q35.
  • Correlation of molecular findings (EcoR1 short fragment) with disease characteristics.

    • Main Results:

    • FSHD is genetically linked to chromosome 4q35, with an EcoR1 short fragment observed in affected individuals.
    • The size of this genetic fragment inversely correlates with disease severity.
    • Despite genetic insights, the precise pathogenic mechanism and the specific causative gene for FSHD remain undetermined.

    Conclusions:

    • Facioscapulohumeral dystrophy (FSHD) has a defined genetic linkage, but the exact molecular cause is unknown.
    • The current lack of understanding of disease mechanisms hinders the development of treatments for FSHD.
    • Further research is crucial to identify the specific gene and pathogenic pathways involved in FSHD.